^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    MYCN expression

    i
    Entrez ID:
    4613
    Related biomarkers:
    Expression
    CNA
    Others
    Apply
    Trial of CUDC-907 in Children and Young Adults with Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma (NCT02909777)
    Phase 1
    Dana-Farber Cancer Institute
    Active, not recruiting
    Last update posted :
    02/13/2025
    Initiation :
    10/01/2016
    Primary completion :
    06/01/2025
    Completion :
    06/01/2025
    MYC • MYCN
    |
    MYCN expression
    |
    fimepinostat (CUDC-907)
    Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma (NCT01798004)
    Phase 1
    Children's Oncology Group
    Active, not recruiting
    Last update posted :
    03/13/2024
    Initiation :
    04/08/2013
    Primary completion :
    07/28/2015
    MYCN
    |
    MYCN amplification • MYCN expression
    |
    cisplatin • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • topotecan • melphalan • mesna • busulfan • Neupogen (filgrastim) • cyclophosphamide intravenous
    Auto Transplant for High Risk or Relapsed Solid or CNS Tumors (NCT01505569)
    Phase N/A
    Masonic Cancer Center, University of Minnesota
    Completed
    Last update posted :
    02/26/2024
    Initiation :
    10/20/2011
    Primary completion :
    02/01/2024
    Completion :
    02/01/2024
    MYCN • CD34
    |
    LDH elevation • MYCN expression
    |
    cisplatin • carboplatin • paclitaxel • ifosfamide • etoposide IV • melphalan • mesna • thiotepa • busulfan
    An Intermediate Expanded Use Trial of DFMO (NCT03581240)
    Phase N/A
    Giselle Sholler
    Available
    Last update posted :
    09/28/2023
    MYCN
    |
    MYCN amplification • MYCN expression
    Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma (NCT01387724)
    Phase N/A
    Children's Oncology Group
    Completed
    Last update posted :
    05/18/2016
    Initiation :
    06/01/2011
    Primary completion :
    05/01/2016
    NTRK2 • MYCN • BDNF
    |
    MYCN amplification • MYCN expression • NTRK expression